2024/09/18 21:14:13 | |
---|---|
Price | |
311.3201 USD | |
Difference | 5.23% (15.46) |
ISIN | US9553061055 |
Symbol | WST |
Exchange | NYSE |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 19,297 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 311.36 USD (400) |
Ask (Ask size) | 312.26 USD (200) |
Open | 297.61 USD |
High | 313.29 USD |
Low | 296.0001 USD |
Close (prev. day) | 295.86 USD |
VWAP | 307.193345 USD |
Volume (pcs) | 457,680 |
Trading volume | 140,842,123.62 |
Number of trades | 13,762 |
Last size | 120 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings | ||
2024/07/12 | Global Equity Ratings |
2024/09/18 21:14:13 | |
---|---|
Price | |
311.3201 USD | |
Difference | 5.23% (15.46) |
ISIN | US9553061055 |
Symbol | WST |
Exchange | NYSE |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 19,297 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 311.36 USD (400) |
Ask (Ask size) | 312.26 USD (200) |
Open | 297.61 USD |
High | 313.29 USD |
Low | 296.0001 USD |
Close (prev. day) | 295.86 USD |
VWAP | 307.193345 USD |
Volume (pcs) | 457,680 |
Trading volume | 140,842,123.62 |
Number of trades | 13,762 |
Last size | 120 |
6m | 1Y | 3Y | |
Perf (%) | -23.67% | -24.94% | -34.05% |
Perf (abs.) | -91.76 | -98.32 | -152.76 |
Beta | - | - | - |
Volatility | 34.58 | 35.80 | 36.50 |
Ø price 5 days | Ø volume 5 days (pcs.) | 298.6280 USD (364,451) |
Ø price 30 days | Ø volume 30 days (pcs.) | 299.9330 USD (405,833) |
Ø price 100 days | Ø volume 100 days (pcs.) | 321.6775 USD (574,208) |
Ø price 250 days | Ø volume 250 days (pcs.) | 347.8780 USD (504,374) |
YTD High | date | 413.7000 USD (2024/02/07) |
YTD Low | date | 265.0000 USD (2024/07/25) |
52 Weeks High | date | 413.7000 USD (2024/02/07) |
52 Weeks Low | date | 265.0000 USD (2024/07/25) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2023/10/25 | 17:35 | 342.50 EUR | 0.00 | 2 |
Tradegate | 2024/09/18 | 13:01 | 268.40 EUR | 0.00 | 1 |
Stuttgart | 2024/09/18 | 08:00 | 263.90 EUR | 0.00 | 1 |
NYSE | 2024/09/18 | 21:14 | 311.3201 USD | 140.84 | 13,762 |
Munich | 2024/09/18 | 08:03 | 268.30 EUR | 0.00 | 1 |
Hanover | 2024/09/18 | 17:25 | 278.20 EUR | 0.00 | 2 |
Frankfurt | 2024/09/18 | 08:04 | 264.10 EUR | 0.00 | 1 |
Duesseldorf | 2024/09/18 | 19:30 | 276.00 EUR | 0.00 | 5 |
Berlin | 2024/09/18 | 08:13 | 264.50 EUR | 0.00 | 1 |
WEST PHARMACEUTICAL SERVICES INC. |
- - |
530 Herman O. West Drive - 19341-0645 Exton |
Telefon: +1-610-594-2900 |
Fax: +1-800-345-9800 |
E-mail: - |
West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA. |
Myla Lai-Goldman | Member of Board of Directors |
Stephen Lockhart | Member of Board of Directors |
William Feehery | Member of Board of Directors |
Deborah Keller | Member of Board of Directors |
Douglas Michels | Member of Board of Directors |
Mark Buthman | Member of Board of Directors |
Molly Joseph | Member of Board of Directors |
Paolo Pucci | Member of Board of Directors |
Robert Friel | Member of Board of Directors |
Thomas Hofmann | Member of Board of Directors |
Eric M. Green | Chairman of Managing Board |
Annette F. Favorite | Member of Executive Committee |
Bernard J. Birkett | Member of Executive Committee |
Cindy Reiss-Clark | Member of Executive Committee |
Silji Abraham | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer